“…Although dopamine and other catecholamines possess antioxidative and free radical scavenging properties (Cao, Sofic, & Prior, 1997; Yen & Hsieh, 1997), dopamine is easily oxidized and generates highly reactive metabolites such as dopamine quinone, which further lead to mitochondrial dysfunction and oxidative stress (Miyazaki & Asanuma, 2008). Thus, it is not surprising to see the “paradoxical effect” of stimulant treatment, which causes oxidative stress (El-Tawil, Abou-Hadeed, El-Bab, & Shalaby, 2011; Martins et al, 2006) but is also neuroprotective (Volz, 2008) and is an effective treatment for ADHD (Faraone & Buitelaar, 2010). In contrast, clonidine, which is also an effective treatment for ADHD, reduces oxidative stress in rats (Filos et al, 2012; Nik Yusoff, Mustapha, Govindasamy, & Sirajudeen, 2013).…”